ADVERTISEMENT
4 /5 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

WuXi NextCode acquires Irish population database

by Rick Mullin
December 1, 2018 | APPEARED IN VOLUME 96, ISSUE 48

 

09648-buscon15-jonescxd.jpg
Credit: Genomics Medicine Ireland
Genomics Medicine Ireland CEO Anne Jones.

WuXi NextCode, the genomics affiliate of WuXi AppTec, has acquired Genomics Medicine Ireland (GMI), a genomics firm launched in 2015. GMI and other investors now plan to spend up to $400 million to establish a genomics database for Ireland. GMI aims to enroll about 10% of the Irish population in a gene-sequencing program in which participants will contribute detailed medical and health data. WuXi claims that data on Ireland’s genetically homogeneous population will create a unique asset for pharmaceutical firms that partner with GMI.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment